Endo Calm
Natural health product licensed in Canada
- Licence holder
- Gab Innovations Inc.
- NPN or DIN-HM
- 80089396
- Status
- Active licence
- Licence date
- 3 December 2018
- Revision date
- 4 July 2022
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Paeonia lactiflora Source : Racine Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 500 milligramme | 20 milligramme | Not calculated |
| Syzygium aromaticum Source : Bourgeon floral Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 125 milligramme | 12.5 milligramme | Not calculated |
| Zanthoxylum bungeanum Source : Fruit pericarp Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 125 milligramme | 12.5 milligramme | Not calculated |
| Echinacea angustifolia Source : Racine Extract : Matériel brut sec Extraction ratio : 18:1 Dry plant equivalent : 180 milligramme | 10 milligramme | Not calculated |
| Magnolia officinalis Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 125 milligramme | 6.25 milligramme | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 300 milligramme | 25 milligramme | Not calculated |
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2 Grammes | 100 milligramme | Not calculated |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 25 milligramme | Not calculated |
Non-medicinal ingredients
Amidon alimentaire, modifié, Carraghénine, Cire de Candelilla, Sorbitol, dérivé sodium-cuivre de la chlorophylline, Eau purifiée, Riboflavine, Lécithine, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to temporarily promote relaxation Ashwagandha is traditionally used in Ayurveda as Rasayana (rejuvenative tonic) Ashwagandha is traditionally used in Ayurveda to relieve general debility, especially during convalescence or old age Ashwagandha is traditionally used in Ayurveda as a sleep aid Ashwagandha is traditionally used in Ayurveda to balance aggravated Vata (nervine tonic, sedative) Ashwagandha is traditionally used in Ayurveda for memory enhancement Ashwagandha is used in Herbal Medicine as an Adaptogen to help increase energy and resistance to stress (e.g. in case of mental and physical fatigue related to stress) Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection, an auto-immune disorder, if you are taking immunosuppressants, if symptoms persist or worsen or for use beyond 8 weeks. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended.
Source
Official Health Canada record, licence 80089396
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging